Published in Am J Clin Pathol on July 01, 2004
Kikuchi-Fujimoto disease. Orphanet J Rare Dis (2006) 2.14
Fatal Kikuchi-Fujimoto disease associated with SLE and hemophagocytic syndrome: a case report. Clin Rheumatol (2008) 1.24
Kikuchi-Fujimoto's disease involving mesenteric nodes: a report and review of literature. BMJ Case Rep (2011) 1.19
Kikuchi-Fujimoto disease: retrospective study of 91 cases and review of the literature. Medicine (Baltimore) (2014) 1.03
Bilateral pleural effusion and interstitial lung disease as unusual manifestations of Kikuchi-Fujimoto disease: case report and literature review. BMC Pulm Med (2010) 0.94
Recurrent lymphadenopathy in children with Kikuchi-Fujimoto disease. Eur J Pediatr (2014) 0.93
Self limited disorder in a young female with fever, abdominal pain and lymphadenopathy: a case report. Cases J (2009) 0.92
Kikuchi-fujimoto disease: clinical and laboratory characteristics and outcome. J Glob Infect Dis (2014) 0.89
Kikuchi-Fujimoto disease mimicking malignant lymphoma with 2-[(18)F]fluoro-2-deoxy-D-glucose PET/CT in children. Korean J Pediatr (2014) 0.89
Kikuchi fujimoto disease. Clin Med Insights Arthritis Musculoskelet Disord (2012) 0.88
Hashimoto's Thyroiditis and Kikuchi's Disease: Presentation of a Case and Review of the Literature. Case Rep Otolaryngol (2012) 0.88
A non-invasive diagnosis of histiocytic necrotizing lymphadenitis by means of gene expression profile analysis of peripheral blood mononuclear cells. J Clin Immunol (2013) 0.85
Kikuchi-Fujimoto and Kimura diseases: the selected, rare causes of neck lymphadenopathy. Eur Arch Otorhinolaryngol (2009) 0.84
Kikuchi-fujimoto disease: a case report and literature review. Case Rep Otolaryngol (2012) 0.83
Kikuchi-fujimoto disease in the United States: three case reports and review of the literature [corrected]. Mediterr J Hematol Infect Dis (2014) 0.83
A rare case of Kikuchi-Fujimoto disease. J Nat Sci Biol Med (2013) 0.83
Recurrent Kikuchi-Fujimoto disease. BMJ Case Rep (2010) 0.83
Kikuchi-Fujimoto disease and acute appendicitis. BMJ Case Rep (2014) 0.83
Kikuchi's disease. J Oral Maxillofac Pathol (2010) 0.82
Management of kikuchi-fujimoto disease using glucocorticoid: a case report. Case Rep Med (2011) 0.82
A case of relapsing kikuchi-fujimoto disease. Case Rep Otolaryngol (2013) 0.82
Kikuchi-fujimoto disease: a rare cause of Fever in the returning traveller. Case Rep Med (2014) 0.82
Fatal Kikuchi-like lymphadenitis associated with connective tissue disease: a report of two cases and review of the literature. Springerplus (2015) 0.81
Cervical lymph node diseases in children. GMS Curr Top Otorhinolaryngol Head Neck Surg (2014) 0.81
Kikuchi-Fujimoto's disease with abdominal pain due to intra-abdominal lymphadenitis. BMJ Case Rep (2014) 0.81
Kikuchi-fujimoto disease as a differential diagnosis for cervical lymphadenopathy in India: a case report and review of literature. Indian J Otolaryngol Head Neck Surg (2011) 0.80
State of the globe: time to revisit kikuchi fujimoto disease. J Glob Infect Dis (2014) 0.80
Comparison of Ultrasonographic Findings of Biopsy-Proven Tuberculous Lymphadenitis and Kikuchi Disease. Korean J Radiol (2015) 0.79
Neuromyelitis optica spectrum disorder in a patient with Kikuchi-Fujimoto disease. Neurol Neuroimmunol Neuroinflamm (2016) 0.79
Kikuchi-Fujimoto disease following vaccination against human papilloma virus infection and Japanese encephalitis. Eur J Pediatr (2012) 0.79
A Patient with Kikuchi's Disease: What Should Pain Clinicians Do? Korean J Pain (2012) 0.79
Clinicopathological review of immunohistochemically defined Kikuchi-Fujimoto disease-including some interesting cases. Clin Rheumatol (2012) 0.79
A rare case of multifocal lymphadenopathy in a young male. Oxf Med Case Reports (2014) 0.79
Recurrent aseptic meningitis in association with Kikuchi-Fujimoto disease: case report and literature review. BMC Neurol (2012) 0.78
Generalized Lymphadenopathy as Presenting Feature of Systemic Lupus Erythematosus: Case Report and Review of the Literature. J Clin Med Res (2016) 0.77
Characteristics of Kikuchi-Fujimoto disease in children compared with adults. Eur J Pediatr (2013) 0.77
Kikuchi's lymphadenopathy: a relatively rare but important cause of lymphadenopathy in Greece, potentially associated with the antiphospholipid syndrome. Rheumatol Int (2009) 0.76
Cervical lymphadenopathy--pitfalls of blind antitubercular treatment. J Health Popul Nutr (2014) 0.76
Recurrence of histiocytic necrotizing lymphadenitis: A case report and literature review. Exp Ther Med (2014) 0.75
Kikuchi-Fujimoto disease: a case report of a multi-drug resistant, grueling disease. Oxf Med Case Reports (2017) 0.75
An uncommon presentation of Kikuchi Fujimoto disease: a case report with literature review. BMC Res Notes (2015) 0.75
Kikuchi-Fujimoto disease associated with Sjogren's syndrome: a case report and review of the literature. Int J Clin Exp Med (2015) 0.75
Systemic Kikuchi-Fujimoto disease bordering lupus lymphadenitis: A fresh look? Intractable Rare Dis Res (2016) 0.75
Fatality in Kikuchi-Fujimoto disease: A rare phenomenon. World J Clin Cases (2017) 0.75
Recurrent Kikuchi's Disease Treated by Hydroxychloroquine. Infect Chemother (2016) 0.75
Cutaneous manifestation of Kikuchi-Fujimoto disease in the setting of granulomatosis with polyangiitis (Wegener's). J Gen Intern Med (2012) 0.75
Kikuchi-Fujimoto Disease Masquerading as Metastatic Papillary Carcinoma of the Thyroid. Int J Angiol (2015) 0.75
Kikuchi-fujimoto disease with bilateral uveitis. J Radiol Case Rep (2009) 0.75
Kikuchi's disease displaying a t(2:16) chromosomal translocation. J Clin Pathol (2007) 0.75
The kikuchi-fujimoto disease in Nigeria: a case report and literature review. Case Rep Med (2014) 0.75
An uncommon presentation of Kikuchi-Fujimoto disease as mediastinal lymphadenopathy. J Thorac Dis (2016) 0.75
Kikuchi-Fujimoto disease presenting after consumption of 'Miracle Mineral Solution' (sodium chlorite). BMJ Case Rep (2014) 0.75
Kikuchi-Fujimoto Disease: A Rare Presentation with Localized Iliac Lymphadenitis. Iran J Med Sci (2017) 0.75
A white man with Kikuchi-Fujimoto disease mimicking lymphoma, preceded by frequent episodes of tonsillitis: a case report. J Med Case Rep (2017) 0.75
Kikuchi disease preceding systemic lupus erythematosus with membranous lupus nephritis. NDT Plus (2009) 0.75
Kikuchi-Fujimoto disease: an unusual cause of neck swelling in pregnancy. BMJ Case Rep (2015) 0.75
Kikuchi-Fujimoto lymphadenitis imitating metastatic melanoma on positron emission tomography: a case report. BMC Surg (2015) 0.75
Histiocytic necrotising lymphadenitis (Kikuchi-Fujimoto disease) of axillary lymph nodes. BMJ Case Rep (2015) 0.75
Kikuchi Disease Mimicking Metastatic Lymphadenopathy on (18)F-FDG PET/CT in Patients with Breast Cancer. Nucl Med Mol Imaging (2015) 0.75
(18)F-Fluorodeoxyglucose positron emission tomography/computed tomography in patients with Kikuchi-Fujimoto disease: a nine-case series in China. Int J Clin Exp Med (2015) 0.75
Aseptic meningitis in Kikuchi's disease mimicking tuberculous meningitis. Neurol Sci (2012) 0.75
Initial work-up for cervical lymphadenopathy: back to basics. Eur Arch Otorhinolaryngol (2011) 0.75
[Lymphadenopathy: demarcation to malignant lymphomas]. Pathologe (2013) 0.75
CT pattern analysis of necrotizing and nonnecrotizing lymph nodes in Kikuchi disease. PLoS One (2017) 0.75
Co-occurrence of Kikuchi-Fujimoto's disease and Still's disease: case report and review of previously reported cases. Clin Rheumatol (2014) 0.75
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med (2002) 24.07
International network of cancer genome projects. Nature (2010) 20.35
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood (2003) 13.92
Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med (2004) 12.20
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature (2010) 8.78
Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med (2010) 8.74
Oncogenically active MYD88 mutations in human lymphoma. Nature (2010) 7.34
Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science (2008) 6.52
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell (2003) 6.11
Molecular diagnosis of Burkitt's lymphoma. N Engl J Med (2006) 6.10
Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med (2003) 6.06
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci U S A (2008) 5.90
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature (2012) 4.33
A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res (2009) 3.87
Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. J Clin Oncol (2012) 3.59
Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma. Cancer Cell (2004) 3.55
BLUEPRINT to decode the epigenetic signature written in blood. Nat Biotechnol (2012) 3.24
EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues. Am J Pathol (2009) 3.15
Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. Blood (2005) 3.12
Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review. JAMA (2007) 2.91
The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status. Blood (2005) 2.82
Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood (2002) 2.57
Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat Rev Cancer (2007) 2.48
Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk. Nat Genet (2010) 2.45
Cooperative epigenetic modulation by cancer amplicon genes. Cancer Cell (2010) 2.43
The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology (2011) 2.42
High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood (2006) 2.40
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients. AIDS (2004) 2.39
Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. J Clin Invest (2011) 2.36
Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker Consortium. J Clin Oncol (2007) 2.35
A new scoring system for prognostic stratification of patients with alcoholic hepatitis. Am J Gastroenterol (2008) 2.35
Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats. Hepatology (2009) 2.33
Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab. J Clin Oncol (2010) 2.30
Type I MOZ/CBP (MYST3/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocation. Genes Chromosomes Cancer (2004) 2.22
BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma. Am J Pathol (2004) 2.20
Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Blood (2005) 2.19
Kikuchi-Fujimoto disease. Orphanet J Rare Dis (2006) 2.14
The BH3-mimetic GX15-070 synergizes with bortezomib in mantle cell lymphoma by enhancing Noxa-mediated activation of Bak. Blood (2007) 2.14
Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP. Blood (2008) 2.14
Antineutrophil cytoplasmic antibodies. Lancet (2006) 2.06
Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis. Hepatology (2012) 2.03
Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation. Hepatology (2006) 2.03
BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma. J Clin Oncol (2006) 2.02
Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study. Blood (2008) 2.00
Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network. Br J Haematol (2005) 1.96
Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma. J Exp Med (2007) 1.94
Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients. Hepatology (2013) 1.93
Molecular pathogenesis of mantle cell lymphoma. J Clin Invest (2012) 1.92
Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP. J Clin Oncol (2013) 1.91
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet (2013) 1.85
MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. Hepatology (2003) 1.85
Dermoscopy improves accuracy of primary care physicians to triage lesions suggestive of skin cancer. J Clin Oncol (2006) 1.81
SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma. Blood (2013) 1.81
CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma. Blood (2012) 1.79
SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica (2009) 1.79
Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis. Gastroenterology (2009) 1.76
Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling. Blood (2010) 1.76
Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue. Blood (2014) 1.71
Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms. Cancer Discov (2014) 1.70
A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma. Blood (2012) 1.68
BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab. Clin Cancer Res (2011) 1.67
Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. Blood (2014) 1.66
Immunotherapy for antineutrophil cytoplasmic antibody-associated vasculitis: challenging the therapeutic status quo? Trends Immunol (2008) 1.64
Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival. Blood (2007) 1.60
The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas. Haematologica (2006) 1.60
Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. Blood (2011) 1.57
Genetics of carney triad: recurrent losses at chromosome 1 but lack of germline mutations in genes associated with paragangliomas and gastrointestinal stromal tumors. J Clin Endocrinol Metab (2007) 1.57
Expression of human equilibrative nucleoside transporter 1 (hENT1) and its correlation with gemcitabine uptake and cytotoxicity in mantle cell lymphoma. Haematologica (2006) 1.55
Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells. J Hepatol (2013) 1.55
Hepatitis C virus receptors claudin-1 and occludin after liver transplantation and influence on early viral kinetics. Hepatology (2011) 1.54
Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways. J Clin Oncol (2005) 1.54
Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium. Blood (2011) 1.51
Most primary adrenal lymphomas are diffuse large B-cell lymphomas with non-germinal center B-cell phenotype, BCL6 gene rearrangement and poor prognosis. Mod Pathol (2009) 1.51
Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA. FASEB J (2006) 1.50
Determination of IL28B polymorphisms in liver biopsies obtained after liver transplantation. J Hepatol (2011) 1.50
Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases. Blood (2011) 1.49
Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations. Blood (2009) 1.46
High-risk cervical epithelial neoplasia grade 1 treated by loop electrosurgical excision: follow-up and value of HPV testing. Am J Obstet Gynecol (2007) 1.46
Prevalence study of nevi in children from Barcelona. Dermoscopy, constitutional and environmental factors. Dermatology (2008) 1.46
Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV. Leuk Lymphoma (2009) 1.46
Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behavior. Haematologica (2010) 1.45
Familial lymphoid neoplasms in patients with mantle cell lymphoma. Haematologica (2004) 1.43
The severe gout of Holy Roman Emperor Charles V. N Engl J Med (2006) 1.43
Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity. Gastroenterology (2006) 1.41
High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma. J Clin Oncol (2009) 1.40
Antigen receptors and somatic hypermutation in B-cell chronic lymphocytic leukemia with Richter's transformation. Haematologica (2006) 1.40
Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature. J Clin Oncol (2007) 1.39
[Liver abscesses following liver transplantation from non-heart-beating donation]. Med Clin (Barc) (2010) 1.39
Cocaine-induced acute hepatitis and thrombotic microangiopathy. JAMA (2005) 1.39
[66-year-old woman presenting with asthenia and eosinophilia]. Med Clin (Barc) (2004) 1.38
[A 73-year-old male with protracted fever and alteration of hepatic parameters]. Med Clin (Barc) (2007) 1.38
Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma. Proc Natl Acad Sci U S A (2006) 1.35
Differential effects of X-ALK fusion proteins on proliferation, transformation, and invasion properties of NIH3T3 cells. Oncogene (2004) 1.35
Clinical significance of minimal residual disease, as assessed by different techniques, after stem cell transplantation for chronic lymphocytic leukemia. Blood (2006) 1.31
Cancer epigenetics and methylation. Science (2002) 1.31
Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms. Br J Haematol (2007) 1.28
Clinicopathologic significance and prognostic value of chromosomal imbalances in diffuse large B-cell lymphomas. J Clin Oncol (2004) 1.27